Filter
Founded in September 2018 and located in New York City, Filter is dedicated to promoting thoughtful and humane perspectives on drug use, drug policy, and human rights through journalism.
Outlet metrics
Global
#842687
United States
#289366
Health/Addictions
#702
Articles
-
3 days ago |
filtermag.org | Alexander Lekhtman
An ongoing advanced clinical trial of psilocybin as a depression treatment reportedly shows great promise. Caution is required when the data have not yet been published. But if confirmed, this could be a landmark in the psychedelic drug’s journey toward federal approval as a medical treatment in the United States.
-
4 days ago |
filtermag.org | Alexander Lekhtman
A Montana proposal that would have allowed tribal nations to negotiate cannabis regulation individually will not be enacted this session. Governor Greg Gianforte (R) vetoed the bill on June 19, calling it “unnecessary and duplicative.” sought to address cannabis industry barriers that tribes in Montana have faced since 2021, when the state enacted HB 701.
-
1 week ago |
filtermag.org | Alexander Lekhtman
Harm reduction advocates in Madison, Wisconsin, are organizing what could be the state’s first authorized public drug-checking program—but with funding and support from local officials still in limbo, they don’t know when they’ll be able to launch. Alan Robinson, founder of cannabis brand Herbal Aspect and former executive director of WI NORML, would be the director of the proposed Narcotics Outreach Chemical Analysis Program (NOCAP).
-
1 week ago |
filtermag.org | Alexander Lekhtman
Virginia will begin punishing fentanyl distribution convictions as involuntary manslaughter, in cases that can be linked to overdose death. In some cases, if it can be determined that no financial gain was involved, the distribution will not be considered manslaughter and carry lighter penalties. The law will take effect July 1. Governor Glenn Youngkin (R) signed SB 746 on June 13.
-
1 week ago |
filtermag.org | Kyle Jaeger
A majority of marijuana consumers disapprove of the Trump administration’s actions on cannabis policy to date, according to the first edition of a new tracking poll from Marijuana Moment and NuggMD. But the survey also shows a significant willingness among users to shift their position if the federal government opts to reschedule or legalize marijuana.
Filter journalists
Contact details
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →